Pfizer 2007 Annual Report Download - page 81

Download and view the complete annual report

Please find page 81 of the 2007 Pfizer annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 85

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85

Geographic
FOR/AS OF THE YEAR ENDED DEC. 31,
(MILLIONS OF DOLLARS) 2007 2006 2005
Revenues
United States(a) $23,153 $25,822 $24,751
Europe/Canada(b) 15,918 14,194 14,355
Japan/Asia(c) 6,511 5,939 5,987
Latin America/AFME(d) 2,836 2,416 2,312
Consolidated $48,418 $48,371 $47,405
Long-lived assets(e)
United States(a) $19,145 $21,795 $24,390
Europe/Canada(b) 15,457 17,538 16,492
Japan/Asia(c) 1,177 1,205 1,154
Latin America/AFME(d) 453 444 441
Consolidated $36,232 $40,982 $42,477
(a) Includes operations in Puerto Rico.
(b) Includes Canada, France, Italy, Spain, Germany, U.K., Ireland, Northern Europe and Central-South Europe.
(c) Includes Japan, Australia, Korea, China, Taiwan, Thailand and India.
(d) Includes South America, Central America, Mexico, Africa and the Middle East.
(e) Long-lived assets include identifiable intangible assets (excluding goodwill) and property, plant and equipment.
Revenues by Therapeutic Area
YEAR ENDED DEC. 31,
(MILLIONS OF DOLLARS) 2007 2006 2005
Pharmaceutical
Cardiovascular and metabolic diseases $18,853 $19,871 $18,732
Central nervous system disorders 5,152 6,038 6,391
Arthritis and pain 2,914 2,711 2,386
Infectious and respiratory diseases 3,552 3,474 4,770
Urology 3,010 2,809 2,684
Oncology 2,640 2,191 1,996
Ophthalmology 1,643 1,461 1,373
Endocrine disorders 1,052 985 1,049
All other 3,819 4,169 3,823
Alliance revenues 1,789 1,374 1,065
Total Pharmaceutical 44,424 45,083 44,269
Animal Health 2,639 2,311 2,206
Other 1,355 977 930
Total revenues $48,418 $48,371 $47,405
2007 Financial Report 79
Notes to Consolidated Financial Statements
Pfizer Inc and Subsidiary Companies